Legal Representation
Attorney
Michael P. Straher
USPTO Deadlines
Application History
48 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 9, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 9, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 8, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 7, 2017 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Dec 1, 2017 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Dec 7, 2017 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 1, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 6, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 2, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jun 2, 2017 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jun 2, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 20, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 19, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Dec 2, 2016 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Dec 2, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 9, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 8, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 2, 2016 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 5, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 27, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 27, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 2, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 2, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 4, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 2, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 2, 2015 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Dec 2, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 2, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 7, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 7, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 18, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 3, 2015 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 3, 2015 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 11, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 11, 2015 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 11, 2015 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2015 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 11, 2015 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 6, 2015 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Jan 27, 2015 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Jan 6, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 5, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2014 | CFDG | O | REQUEST TO CORRECT FILING DATE - GRANTED | Loading... |
| Nov 17, 2014 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Nov 4, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 24, 2014 | RCFR | I | REQUEST TO CORRECT FILING DATE RECEIVED | Loading... |
| Oct 28, 2014 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Oct 24, 2014 | FAXX | I | FAX RECEIVED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for neurological use, Attention Deficit Hyperactivity Disorder, psychiatric diseases and disorders, all of which contain a compound that is a norepinephrine and dopamine-preferring triple reuptake inhibitor
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005